Skip to main navigation Skip to search Skip to main content

Australian pharmacists' experiences and perspectives in implementing a chronic kidney disease screening service in community pharmacies: a qualitative study

  • Ayana Korsa
  • , Ines Krass
  • , Connie Van
  • , Wubshet Tesfaye
  • , Natasa Gisev
  • , Anh Tran
  • , Rita McMorrow
  • , Breonny Robson
  • , Judith Fethney
  • , Vincent Versace
  • , Kamal Sud
  • , Lukas Kairaitis
  • , David Johnson
  • , Judy Mullan
  • , Sanjyot Vagholkar
  • , Ronald L. Castelino
  • The University of Sydney
  • Wallaga University
  • University of Queensland
  • University of New South Wales
  • University of Melbourne
  • Kidney Health Australia
  • Deakin University
  • Nepean Hospital
  • Blacktown Hospital
  • Princess Alexandra Hospital
  • University of Queensland
  • University of Wollongong
  • Macquarie University

Research output: Contribution to journalArticlepeer-review

28 Downloads (Pure)

Abstract

Background: The emerging role of pharmacists in chronic kidney disease (CKD) care prompted the pharmacy-led screening and quality use of medicines in CKD trial (QUM-CKD), a pharmacy-led screening initiative to detect previously undiagnosed CKD and improve medication safety.Objective: To explore pharmacists' experiences and perspectives on the implementation of the QUM-CKD trial in Australian community pharmacies. Methods: A descriptive phenomenological qualitative approach was employed, involving in-depth, semi-structured telephone interviews with thirteen metropolitan and rural community pharmacists in the trial. Pharmacists were selected via purposive maximum variation sampling and were recruited mid-trial. Interviews were audio- recorded, transcribed verbatim, and thematically analysed using both deductive and inductive approaches in NVivo 14. Results: Most participating pharmacists reported having positive experiences with the trial's implementation. Facilitators of implementation included pharmacists' knowledge and beliefs, the availability of resources, support and training. The alignment with roles, values, and systems, along with perceived benefits of the service, the point-of-care testing service, a whole-team approach, and patient acceptance coupled with positive feedback, also facilitated implementation. Barriers included insufficient pharmacist staffing, time constraints, heavy workload, trial software and documentation issues, patients' lack of time, interest or unfavourable perceptions of the service, and interprofessional communication challenges between pharmacists and general practitioners (GPs). Pharmacists also suggested several potential improvements and expressed concerns about the sustainability of the service. Conclusions: Australian community pharmacists generally reported positive experiences in implementing the QUM-CKD trial. To ensure the service's success and sustainability, we recommend adequate pharmacy staffing, appropriate pharmacist remuneration, active stakeholder promotion and strong interprofessional collaboration. Pharmacists' suggestions for service improvement should also be considered.

Original languageEnglish
Article number100643
Number of pages9
JournalExploratory Research in Clinical and Social Pharmacy
Volume20
DOIs
Publication statusPublished - Dec 2025

Open Access - Access Right Statement

Published by Elsevier Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chronic kidney disease screening
  • Community pharmacy services
  • Pharmacists' experience
  • Qualitative research

Fingerprint

Dive into the research topics of 'Australian pharmacists' experiences and perspectives in implementing a chronic kidney disease screening service in community pharmacies: a qualitative study'. Together they form a unique fingerprint.

Cite this